Alterity Therapeutics Limited

Alterity Therapeutics Limited

ATHE · Nasdaq

Alterity Therapeutics Limited (ATHE) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Alterity Therapeutics Limited in 2026. The next earnings report is expected on August 28, 2026.

Earnings calendar

Next earnings date

28 Aug 2026

In 8 days

EPS estimate

-0.12

Revenue estimate

2.3M

Past earnings

25 Feb 2026
EPS actual
-0.38 (-65.9%)
estimate -0.23
Revenue actual
645.9K (-39.6%)
estimate 1.1M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Sector
Healthcare
Industry
Biotechnology
Country
Australia
Exchange
Nasdaq
CEO
David A. Stamler
Employees
10
IPO date
29 Sep 2003
ISIN
US02155X2053
Website
alteritytherapeutics.com

Frequently asked questions

When does Alterity Therapeutics Limited (ATHE) next report earnings?

Alterity Therapeutics Limited (ATHE) is scheduled to report earnings on August 28, 2026.

What was Alterity Therapeutics Limited's most recent earnings date?

Alterity Therapeutics Limited (ATHE) last reported earnings on February 25, 2026.

Where is Alterity Therapeutics Limited stock listed?

Alterity Therapeutics Limited (ATHE) is listed on Nasdaq.